PubMed

A consultant-extender system for breast cancer adjuvant chemotherapy.

Wirtschafter D, Carpenter JT, Mesel E.

Ann Intern Med. 1979 Mar;90(3):396-401.PMID: 426409 [PubMed - indexed for MEDLINE]Related articles

A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.

Foy JM, Earls MF.

Pediatrics. 2005 Jan;115(1):e97-104.PMID: 15629972 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.

Liberato NL, Marchetti M, Barosi G.

J Clin Oncol. 2007 Feb 20;25(6):625-33. Erratum in: J Clin Oncol. 2007 Sep 1;25(25):4030. PMID: 17308267 [PubMed - indexed for MEDLINE]Related articles

Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community.

Studnicki J, Schapira DV, Bradham DD, Clark RA, Jarrett A.

Cancer. 1993 Nov 15;72(10):2986-92.PMID: 8221566 [PubMed - indexed for MEDLINE]Related articles

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.PMID: 10545862 [PubMed - as supplied by publisher]Related articlesFree article

Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.

Dignam JJ.

J Natl Cancer Inst Monogr. 2001;(30):36-43.PMID: 11773290 [PubMed - indexed for MEDLINE]Related articles

Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population-based study on 1547 patients.

Palazzi M, De Tomasi D, D'Affronto C, Richetti A, Valli MC, Meregalli S, Asnaghi D, Arienti V, Cavallini D, Pradella R, Cafaro I, Baroncelli G, Di Lorenzo I, De Agostini A, Parrinello G, Bertoni F.

Tumori. 2002 Nov-Dec;88(6):503-6.PMID: 12597147 [PubMed - indexed for MEDLINE]Related articles

A computerized system for reviewing medical records from physicians' offices.

Garnick DW, Lawthers AG, Palmer RH, Moentmann SJ, Fowles J, Weiner JP.

Jt Comm J Qual Improv. 1994 Dec;20(12):679-94.PMID: 7881518 [PubMed - indexed for MEDLINE]Related articles

Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.

Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, Grant A, Campbell MK, Miedyzbrodzka Z, Clarke A, Watson MS, Douglas A.

Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. Review.PMID: 15694064 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.

Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL.

Cancer. 2005 Nov 15;104(10):2054-62.PMID: 16216002 [PubMed - indexed for MEDLINE]Related articlesFree article

Adjuvant therapy for breast cancer: practice patterns of community physicians.

Harlan LC, Abrams J, Warren JL, Clegg L, Stevens J, Ballard-Barbash R.

J Clin Oncol. 2002 Apr 1;20(7):1809-17.PMID: 11919238 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy dose intensity determination as a quality of care measure for managed care organizations in the treatment of early-stage breast cancer.

Morrow T, Siegel M, Boone S, Lawless G, Carter W.

Am J Med Qual. 2002 Nov-Dec;17(6):218-24.PMID: 12487337 [PubMed - indexed for MEDLINE]Related articles

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.PMID: 11512506 [PubMed - indexed for MEDLINE]Related articles

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.

Lokich JJ, Moore CL, Anderson NR.

Cancer. 1996 Jul 15;78(2):294-9.PMID: 8674006 [PubMed - indexed for MEDLINE]Related articles

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French. PMID: 15959450 [PubMed - indexed for MEDLINE]Related articles

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D.

J Natl Cancer Inst. 2001 Jul 4;93(13):979-89. Review.PMID: 11438563 [PubMed - indexed for MEDLINE]Related articlesFree article

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L; Cancer and Leukemia Group B.

JAMA. 2005 Mar 2;293(9):1073-81.PMID: 15741529 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer.

Kurian AW, Thompson RN, Gaw AF, Arai S, Ortiz R, Garber AM.

J Clin Oncol. 2007 Feb 20;25(6):634-41.PMID: 17308268 [PubMed - indexed for MEDLINE]Related articles